Saffari, A. (03 May 2019). Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study. Orphanet journal of rare diseases, 14, . doi:10.1186/s13023-019-1077-6

"Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study / Afshin Saffari, Ines Brösse, Adelheid Wiemer-Kruel, Bernd Wilken, Paula Kreuzaler, Andreas Hahn, Matthias K. Bernhard, Cornelis M. van Tilburg, Georg F. Hoffmann, Matthias Gorenflo, Sven Hethey, Olaf Kaiser, Stefan Kölker, Robert Wagner, Olaf Witt, Andreas Merkenschlager, Andreas Möckel, Timo Roser, Jan-Ulrich Schlump, Antje Serfling, Juliane Spiegler, Till Milde, Andreas Ziegler and Steffen Syrbe" Orphanet Journal of Rare Diseases .

Saffari, Afshin. "Safety and Efficacy of MTOR Inhibitor Treatment in Patients With Tuberous Sclerosis Complex Under 2 years of Age - a Multicenter Retrospective Study." Orphanet Journal of Rare Diseases 14 (03 May 2019).